World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   9391 records for 1665 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusProspective RegistrationMain ID Public TitleDate of RegistrationResults available
RecruitingYesNCT03498521
A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site 05/04/2018 
AuthorisedYesEUCTR2017-003510-16-SE
Effect of Sotagliflozin on Cardiovascular Events in Patients with Type 2 Diabètes Post Worsening Heart Failure (SOLOIST-WHF Trial)
Recruitment statusMain IDPublic titleDate of registrationResults available
Not recruitingNCT03521934 Effect of Sotagliflozin on Cardiovascular Events in Patients With Type 2 Diabetes Post Worsening Heart Failure (SOLOIST-WHF Trial) 30/04/2018 
16/03/2018 
Not recruitingYesNCT03466411
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
08/03/2018 
Not recruitingYesNCT03456076
A Study Comparing Adjuvant Alectinib Versus Adjuvant Platinum-Based Chemotherapy in Participants With ALK Positive Non-Small Cell Lung Cancer
06/03/2018 
AuthorisedYesEUCTR2017-002698-20-ES
A clinical study of OPT-302 with ranibizumab compared to ranibizumab alone in patients with neovascular age-related macular degeneration
15/02/2018Yes
AuthorisedYesEUCTR2017-004059-22-LT
Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy 12/02/2018 
AuthorisedYesEUCTR2017-004059-22-DK
Phase III study in first-line treatment of patients with metastatic colorectal cancer who are not candidate for intensive therapy
08/02/2018 
RecruitingYesNCT03426345
Study to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis Study 02
02/02/2018 
AuthorisedYesEUCTR2017-004294-14-LT
Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-004294-14-GR Multicenter Study of Oral Ozanimod as Maintenance Therapy in patients with Moderately to Severely Active Crohn’s Disease 28/02/2018 
01/02/2018 
AuthorisedYesEUCTR2017-004295-55-LT
Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease
Recruitment statusMain IDPublic titleDate of registrationResults available
AuthorisedEUCTR2017-004295-55-GR Multicenter Extension Study of Oral Ozanimod in patients with Moderately to Severely Active Crohn’s Disease 01/03/2018 
01/02/2018 
      
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history